EXOR GROUP – Consolidated Statement of Financial Position - Shortened

€ million Note 12/31/2012   12/31/2011 Change
Non-current assets          
Investments accounted for using the equity method 7 5.005,3   4.822,6 182,7
Other financial assets:          
- Investments measured at fair value 8 2.236,3   1.734,6 501,7
- Other investments 9 544,4   206,5 337,9
- Other financial assets   15,6 (a) 1,0 14,6
Other property, plant and equipment and intangible assets   0,3   0,7 (0,4)
Total Non-current assets   7.801,9   6.765,4 1.036,5
Current assets          
Financial assets and cash and cash equivalents 11 752,0   701,0 51,0
Tax receivables and other receivables   5,8   27,5 (21,7)
Total Current assets   757,8   728,5 29,3
Non-current assets held for sale   7,4 (b) 70,3 (62,9)
Total Assets   8.567,1   7.564,2 1.002,9
Issued capital and reserves attributable to owners of the parent 10 7.164,4   6.403,4 761,0
Non-current liabilities          
Bonds and other financial debt 11 1.279,5   1.045,8 233,7
Provisions for employee benefits   2,4   2,2 0,2
Deferred tax liabilities, other liabilities and provisions for risk   6,4 (c) 6,5 (0,1)
Total Non-current liabilities   1.288,3   1.054,5 233,8
Current liabilities          
Bonds, bank debt and other financial liabilities 11 108,5   96,3 12,2
Other liabilities   5,9   10,0 (4,1)
Total Current liabilities   114,4   106,3 8,1
Total Equity and Liabilities   8.567,1   7.564,2 1.002,9
(a) Includes mainly the financial receivable by EXOR from Alpitour for €14.7 million, which is the remaining balance of the Deferred Price on the sale of Alpitour (€15 million), inclusive of interest capitalized during the year (€0.8 million) calculated using an annual 8% interest rate and adjusted by expenses (€1.1 million) for the settlement of certain disputes that arose with the buyer in the period subsequent to acquisition and relating to events prior to the sale by EXOR. This receivable is not included in the net financial position balance. (b) Relates to the measurement of Perfect Vision convertible bonds and the embedded derivative instrument, carried out on the basis of the criteria set out in the sales agreement signed on December 23, 2011 by EXOR S.A. and Vision Investment Management Ltd., subsequently modified in the early months of 2013. (c) Includes the estimate of expenses for €3.5 million provided for the disputes which arose with the Alpitour buyer in the period subsequent to acquisition and relating to events prior to the sale by EXOR, which presumably will be settled during 2013.

Download xls

Commercial Register No.64236277 Legal notes | Credits